{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T18:32:23Z","timestamp":1795199543718,"version":"4.10.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T00:00:00Z","timestamp":1648598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T00:00:00Z","timestamp":1648598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004101","name":"Lady Tata Memorial Trust, India","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004101","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Increased HbA<jats:sub>2<\/jats:sub> levels are the characteristic feature of \u03b2-thalassemia carriers. A subset of carriers however do not show HbA<jats:sub>2<\/jats:sub> levels in the typical carrier range (\u2265\u20094.0%) but show borderline HbA<jats:sub>2<\/jats:sub> levels. As a result, these carriers escape diagnosis and carry the risk of having \u03b2-thalassemia major offspring. Borderline HbA<jats:sub>2<\/jats:sub> values may occur as a consequence of mild \u03b2-thalassemia mutations, co-inherited \u03b2-thalassemia and \u03b1- or \u03b4- thalassemia or iron deficiency anemia. However, there is insufficient knowledge regarding the cause of borderline HbA<jats:sub>2<\/jats:sub> levels in specific populations. This study aimed to identify the determinants of borderline HbA<jats:sub>2<\/jats:sub> levels (which we have considered as HbA<jats:sub>2<\/jats:sub> 3.0\u20133.9%) in 205 individuals. Primary screening involved detecting the presence of iron deficiency anemia followed by molecular analysis of \u03b1, \u03b2 and \u03b4 globin\u00a0genes. Remarkably, 168 of 205\u00a0individuals were positive for a defect. 87% (149\/168) of positive individuals were heterozygous for \u03b2 thalassemia with (59\/149) or without (90\/149) the presence of co-existing IDA, \u03b1 or \u03b4 gene defects. Notably, 20 of 149 \u03b2 thalassemia carriers showed HbA<jats:sub>2<\/jats:sub>\u2009&lt;\u20093.5% and MCV\u2009&gt;\u200980fL. 7 of these 20 carriers were married to carriers of hemoglobinopathies. Our findings describe the genetic basis of borderline HbA<jats:sub>2<\/jats:sub> levels and emphasize the necessity of a molecular diagnosis in\u00a0these individuals in the routine clinical setting.<\/jats:p>","DOI":"10.1038\/s41598-022-09250-5","type":"journal-article","created":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T18:04:05Z","timestamp":1648663445000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Significance of borderline HbA2 levels in \u03b2 thalassemia carrier screening"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4083-9815","authenticated-orcid":false,"given":"Stacy","family":"Colaco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8584-0583","authenticated-orcid":false,"given":"Roshan","family":"Colah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6039-924X","authenticated-orcid":false,"given":"Anita","family":"Nadkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,30]]},"reference":[{"key":"9250_CR1","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1016\/j.clinbiochem.2009.06.026","volume":"42","author":"A Giambona","year":"2009","unstructured":"Giambona, A. et al. The significance of the haemoglobin A2 value in screening for haemoglobinopathies. Clin. Biochem. 42, 1786\u20131796. https:\/\/doi.org\/10.1016\/j.clinbiochem.2009.06.026 (2009).","journal-title":"Clin. Biochem."},{"key":"9250_CR2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1515\/CCLM.2007.002","volume":"45","author":"R Paleari","year":"2007","unstructured":"Paleari, R. et al. External quality assessment of haemoglobin A2 measurement: data from an Italian pilot study with fresh whole blood subjects and commercial HPLC systems. Clin. Chem. Lab. Med. 45, 88\u201392. https:\/\/doi.org\/10.1515\/CCLM.2007.002 (2007).","journal-title":"Clin. Chem. Lab. Med."},{"key":"9250_CR3","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1056\/NEJMra050436","volume":"353","author":"D Rund","year":"2005","unstructured":"Rund, D. & Rachmilewitz, E. Beta-thalassaemia. N. Engl. J. Med. 353, 1135\u20131146. https:\/\/doi.org\/10.1056\/NEJMra050436 (2005).","journal-title":"N. Engl. J. Med."},{"key":"9250_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1136\/jcp.2008.056945","volume":"62","author":"A Mosca","year":"2009","unstructured":"Mosca, A., Paleari, R., Ivaldi, G., Galanello, R. & Giordano, P. C. The role of haemoglobin A2 testing in the diagnosis of thalassaemias and related haemoglobinopathies. J. Clin. Pathol. 62, 13\u201317. https:\/\/doi.org\/10.1136\/jcp.2008.056945 (2009).","journal-title":"J. Clin. Pathol."},{"key":"9250_CR5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4081\/thal.2012.e4","volume":"2","author":"M Vinciguerra","year":"2012","unstructured":"Vinciguerra, M. et al. Role of novel and rare nucleotide substitutions of the \u03b2-globin gene. Thal. Rep. 2, 4. https:\/\/doi.org\/10.4081\/thal.2012.e4 (2012).","journal-title":"Thal. Rep."},{"key":"9250_CR6","first-page":"25","volume":"8","author":"M Tzetis","year":"1994","unstructured":"Tzetis, M., Traeger-Synodinos, J., Kanavakis, E., Metaxotou-Mavromati, A. & Kattamis, C. The molecular basis of normal HbA2 (type 2) beta-thalassaemia in Greece. Hematol. Pathol. 8, 25\u201334 (1994).","journal-title":"Hematol. Pathol."},{"key":"9250_CR7","doi-asserted-by":"publisher","first-page":"8594","DOI":"10.1155\/2013\/858294","volume":"1","author":"S Denic","year":"2013","unstructured":"Denic, S. et al. Haemoglobin A2 lowered by iron deficiency and \u03b1 -thalassaemia: Should screening recommendation for \u03b2 -thalassaemia Change?. ISRN Hematol. 1, 8594. https:\/\/doi.org\/10.1155\/2013\/858294 (2013).","journal-title":"ISRN Hematol."},{"key":"9250_CR8","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3109\/03630269.2013.785434","volume":"37","author":"NJ Al Moamen","year":"2013","unstructured":"Al Moamen, N. J. et al. Silent \u03b2-thalassaemia mutations at \u2212101 (C>T) and \u221271 (C>T) and their coinheritance with the sickle cell mutation in Bahrain. Haemoglobin 37, 369\u2013377. https:\/\/doi.org\/10.3109\/03630269.2013.785434 (2013).","journal-title":"Haemoglobin"},{"key":"9250_CR9","first-page":"167","volume":"26","author":"A Karim","year":"2009","unstructured":"Karim, A., Usman, M., Moinuddin, M. & Babar, S. U. Cap+ 1 mutation; an unsuspected cause of beta thalassaemia transmission in Pakistan. Turk. J. Haematol. 26, 167\u2013170 (2009).","journal-title":"Turk. J. Haematol."},{"key":"9250_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrrev.2021.108387","volume":"10","author":"S Colaco","year":"2021","unstructured":"Colaco, S. & Nadkarni, A. Borderline HbA2 levels: Dilemma in diagnosis of beta-thalassaemia carriers. Mutat. Res.\/Rev. Mutat. Res. 10, 108387. https:\/\/doi.org\/10.1016\/j.mrrev.2021.108387 (2021).","journal-title":"Mutat. Res.\/Rev. Mutat. Res."},{"key":"9250_CR11","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s12098-007-0117-8","volume":"74","author":"RB Colah","year":"2007","unstructured":"Colah, R. B. et al. HPLC studies in haemoglobinopathies. Indian J. Pediatr. 74, 657\u2013662. https:\/\/doi.org\/10.1007\/s12098-007-0117-8 (2007).","journal-title":"Indian J Pediatr."},{"key":"9250_CR12","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1515\/CCLM.2011.696","volume":"49","author":"A Rangan","year":"2011","unstructured":"Rangan, A. et al. \u03b2-Thalassaemia mutations in subjects with borderline HbA2 values: A pilot study in North India. Clin. Chem. Lab. Med. 49, 2069\u20132072. https:\/\/doi.org\/10.1515\/CCLM.2011.696 (2011).","journal-title":"Clin. Chem. Lab. Med."},{"key":"9250_CR13","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/ijlh.12948","volume":"41","author":"A Nadkarni","year":"2019","unstructured":"Nadkarni, A. et al. The phenotypic and molecular diversity of haemoglobinopathies in India: A review of 15 years at a referral centre. Int. J. Lab. Hematol. 41, 218\u2013226. https:\/\/doi.org\/10.1111\/ijlh.12948 (2019).","journal-title":"Int. J. Lab. Hematol."},{"key":"9250_CR14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.phoj.2017.10.002","volume":"2","author":"R Colah","year":"2017","unstructured":"Colah, R., Italia, K. & Gorakshakar, A. Burden of thalassaemia in India: The road map for control. Pediatr. Hematol. Oncol. J. 2, 79\u201384. https:\/\/doi.org\/10.1016\/j.phoj.2017.10.002 (2017).","journal-title":"Pediatr. Hematol. Oncol. J."},{"key":"9250_CR15","first-page":"10","volume":"15","author":"RB Colah","year":"1997","unstructured":"Colah, R. B. et al. Application of covalent reverse dot blot hybridisation for rapid prental diagnosis of the common Indian thalassaemia syndromes. Ind. J. Hematol. Blood Transf. 15, 10\u201313 (1997).","journal-title":"Ind. J. Hematol. Blood Transf."},{"key":"9250_CR16","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1309\/AJCP70ORBRURVSJM","volume":"133","author":"A Nadkarni","year":"2010","unstructured":"Nadkarni, A. et al. Molecular Diversity of Hb H disease in India. Am. J. Clin. Pathol. 133, 491\u2013494. https:\/\/doi.org\/10.1309\/AJCP70ORBRURVSJM (2010).","journal-title":"Am. J. Clin. Pathol."},{"key":"9250_CR17","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/j.cca.2012.05.019","volume":"413","author":"S Colaco","year":"2012","unstructured":"Colaco, S., Colah, R., Ghosh, K. & Nadkarni, A. Compromising for carrier detection of beta thalassaemia based on measurement of HbA2 levels in unusual cases. Clin. Chim Acta. 413, 1705\u20131707. https:\/\/doi.org\/10.1016\/j.cca.2012.05.019 (2012).","journal-title":"Clin. Chim Acta."},{"key":"9250_CR18","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s40265-020-01341-9","volume":"80","author":"I Motta","year":"2020","unstructured":"Motta, I., Bou-Fakhredin, R., Taher, A. T. & Cappellini, M. D. Beta thalassaemia: New therapeutic options beyond transfusion and iron chelation. Drugs 80, 1053\u20131063. https:\/\/doi.org\/10.1007\/s40265-020-01341-9 (2020).","journal-title":"Drugs"},{"key":"9250_CR19","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/gim.2016.173","volume":"19","author":"R Origa","year":"2017","unstructured":"Origa, R. \u03b2-Thalassaemia. Genet. Med. 19, 609\u2013619. https:\/\/doi.org\/10.1038\/gim.2016.173 (2017).","journal-title":"Genet. Med."},{"key":"9250_CR20","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/pd.4706","volume":"35","author":"M Gorivale","year":"2015","unstructured":"Gorivale, M. et al. Challenges in prenatal diagnosis of beta thalassaemia: couples with normal HbA2 in one partner. Prenat. Diagn. 35, 1353\u20131357. https:\/\/doi.org\/10.1002\/pd.4706 (2015).","journal-title":"Prenat. Diagn."},{"key":"9250_CR21","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1515\/cclm-2016-0470","volume":"55","author":"P Rungsee","year":"2017","unstructured":"Rungsee, P., Kongthai, K. & Pornprasert, S. Detection of the common South-East Asian \u03b20-thalassaemia mutations in subjects with borderline HbA2 levels. Clin. Chem. Lab. Med. 55, e17-20. https:\/\/doi.org\/10.1515\/cclm-2016-0470 (2017).","journal-title":"Clin. Chem. Lab. Med."},{"key":"9250_CR22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4172\/2155-9864.1000396","volume":"8","author":"B Rosnah","year":"2017","unstructured":"Rosnah, B., Shahida, N. S., Nazri, M. H., Marini, R. & Noor Haslina, M. N. The diagnosis of beta thalassaemia with borderline HbA2 level among kelantan population. J. Blood Disord. Transfus. 8, 2. https:\/\/doi.org\/10.4172\/2155-9864.1000396 (2017).","journal-title":"J. Blood Disord. Transfus."},{"key":"9250_CR23","doi-asserted-by":"publisher","first-page":"230","DOI":"10.5114\/aoms.2018.72245","volume":"14","author":"JF Borgio","year":"2018","unstructured":"Borgio, J. F. et al. KLF1 gene and borderline haemoglobin A2 in Saudi population. Arch. Med. Sci. 14, 230. https:\/\/doi.org\/10.5114\/aoms.2018.72245 (2018).","journal-title":"Arch. Med. Sci."},{"key":"9250_CR24","first-page":"552","volume":"134","author":"RB Colah","year":"2011","unstructured":"Colah, R. B., Gorakshakar, A. C. & Nadkarni, A. H. Invasive & non- invasive approaches for prenatal diagnosis of haemoglobinopathies: experiences from India. Indian J. Med. Res. 134, 552 (2011).","journal-title":"Indian J. Med. Res."},{"key":"9250_CR25","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/j.1600-0609.2007.00949.x","volume":"79","author":"A Morgado","year":"2007","unstructured":"Morgado, A. et al. Mutational spectrum of delta-globin gene in the Portuguese population. Eur. J. Haematol. 79, 422\u2013428. https:\/\/doi.org\/10.1111\/j.1600-0609.2007.00949.x (2007).","journal-title":"Eur. J. Haematol."},{"key":"9250_CR26","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/ijlh.12413","volume":"37","author":"AD Stephens","year":"2015","unstructured":"Stephens, A. D. et al. International Council for Standardization in Haematology (ICSH). ICSH recommendations for assessing automated high-performance liquid chromatography and capillary electrophoresis equipment for the quantitation of HbA2. Int. J. Lab. Hematol. 37, 577\u2013582. https:\/\/doi.org\/10.1111\/ijlh.12413 (2015).","journal-title":"Int. J. Lab. Hematol."},{"key":"9250_CR27","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/ajh.2830460204","volume":"46","author":"R Galanello","year":"1994","unstructured":"Galanello, R. et al. Genotype of subjects with borderline haemoglobin A2 levels: Implication for, \u03b2-thalassaemia carrier screening. Am. J. Hematol. 46, 79\u201381. https:\/\/doi.org\/10.1002\/ajh.2830460204 (1994).","journal-title":"Am. J. Hematol."},{"key":"9250_CR28","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1515\/cclm-2013-0098","volume":"51","author":"V Viprakasit","year":"2013","unstructured":"Viprakasit, V. et al. Problems in determining thalassaemia carrier status in a program for prevention and control of severe thalassaemia syndromes: a lesson from Thailand. Clin. Chem. Lab. Med. 51, 1605\u20131614. https:\/\/doi.org\/10.1515\/cclm-2013-0098 (2013).","journal-title":"Clin. Chem. Lab. Med."},{"key":"9250_CR29","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1089\/gte.2007.0080","volume":"12","author":"A Nadkarni","year":"2008","unstructured":"Nadkarni, A., Phanasgaokar, S., Colah, R., Mohanty, D. & Ghosh, K. Prevalence and molecular characterization of \u03b2-thalassaemia syndromes among Indians. Genet. Test. 12, 177\u20131780. https:\/\/doi.org\/10.1089\/gte.2007.0080 (2008).","journal-title":"Genet. Test."},{"key":"9250_CR30","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1080\/03630269.2020.1826327","volume":"44","author":"S Satthakarn","year":"2020","unstructured":"Satthakarn, S., Panyasai, S. & Pornprasert, S. Molecular Characterization of \u03b2-and \u03b1-Globin Gene Mutations in Individuals with Borderline Hb A2 Levels. Haemoglobin 44, 349\u2013353. https:\/\/doi.org\/10.1080\/03630269.2020.1826327 (2020).","journal-title":"Haemoglobin"},{"key":"9250_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3109\/03630268408996958","volume":"8","author":"C Rosatelli","year":"1984","unstructured":"Rosatelli, C. et al. Haematological phenotype of the double heterozygous state for \u03b1 and \u03b2 thalassaemia. Haemoglobin 8, 25\u201335. https:\/\/doi.org\/10.3109\/03630268408996958 (1984).","journal-title":"Haemoglobin"},{"key":"9250_CR32","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.bcmd.2011.05.003","volume":"47","author":"S Yamsri","year":"2011","unstructured":"Yamsri, S., Sanchaisuriya, K., Fucharoen, G., Sae-Ung, N. & Fucharoen, S. Genotype and phenotype characterizations in a large cohort of \u03b2-thalassaemia heterozygote with different forms of \u03b1-thalassaemia in northeast Thailand. Blood Cells Mol. Dis. 47, 120\u2013124. https:\/\/doi.org\/10.1016\/j.bcmd.2011.05.003 (2011).","journal-title":"Blood Cells Mol. Dis."},{"key":"9250_CR33","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3109\/03630269.2010.511591","volume":"34","author":"M Phylipsen","year":"2010","unstructured":"Phylipsen, M. et al. New and known \u03b2-thalassaemia determinants masked by known and new \u03b4 gene defects [HbA[2]-Ramallah or \u03b46[A3]Glu>Gln, GAG> CAG]. Haemoglobin 34, 445\u2013450. https:\/\/doi.org\/10.3109\/03630269.2010.511591 (2010).","journal-title":"Haemoglobin"},{"key":"9250_CR34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3109\/03630269.2013.852568","volume":"38","author":"S Colaco","year":"2014","unstructured":"Colaco, S., Trivedi, A., Colah, R., Ghosh, K. & Nadkarni, A. Masking of a beta thalassaemia determinant by a novel delta globin defect [HbA2- Saurashtra or \u03b4100(G2)Pro>Ser, HBDc.301C>T] in cis. Haemoglobin 38, 24\u201327. https:\/\/doi.org\/10.3109\/03630269.2013.852568 (2014).","journal-title":"Haemoglobin"},{"key":"9250_CR35","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1046\/j.1365-2257.2002.00464.x","volume":"24","author":"I El-Agouza","year":"2002","unstructured":"El-Agouza, I., Abu Shahla, A. & Sirdah, M. The effect of iron deficiency anaemia on the levels of haemoglobin subtypes: Possible consequences for clinical diagnosis. Clin. Lab. Haematol. 24, 285\u2013289. https:\/\/doi.org\/10.1046\/j.1365-2257.2002.00464.x (2002).","journal-title":"Clin. Lab. Haematol."},{"key":"9250_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1751-553X.2011.01368.x","volume":"34","author":"AD Stephens","year":"2012","unstructured":"Stephens, A. D. et al. International Council for the Standardisation of Haematology (ICSH): ICSH recommendations for the measurement of haemoglobin A2. Int. J. Lab. Hematol. 34, 1\u201313. https:\/\/doi.org\/10.1111\/j.1751-553X.2011.01368.x (2012).","journal-title":"Int. J. Lab. Hematol."},{"key":"9250_CR37","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/ijlh.12246","volume":"37","author":"P Sharma","year":"2015","unstructured":"Sharma, P. et al. Impact of iron deficiency on haemoglobin A2% in obligate \u03b2-thalassaemia heterozygotes. Int. J. Lab. Hematol. 37, 105\u2013111. https:\/\/doi.org\/10.1111\/ijlh.12246 (2015).","journal-title":"Int. J. Lab. Hematol."},{"key":"9250_CR38","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3109\/03630269.2014.913517","volume":"38","author":"D Mohanty","year":"2014","unstructured":"Mohanty, D. et al. Interaction of iron deficiency anemia and haemoglobinopathies among college students and pregnant women: A multi center evaluation in India. Haemoglobin. 38, 252\u2013257. https:\/\/doi.org\/10.3109\/03630269.2014.913517 (2014).","journal-title":"Haemoglobin."},{"key":"9250_CR39","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/j.ygeno.2018.11.032","volume":"111","author":"P Hariharan","year":"2019","unstructured":"Hariharan, P., Colah, R., Ghosh, K. & Anita, N. Differential role of Kruppel like factor 1 (KLF1) gene in red blood cell disorders. Genomics 111, 1771\u20131776. https:\/\/doi.org\/10.1016\/j.ygeno.2018.11.032 (2019).","journal-title":"Genomics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09250-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09250-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09250-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T01:14:27Z","timestamp":1669338867000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09250-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,30]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["9250"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-09250-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,30]]},"assertion":[{"value":"29 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5414"}}